Researchers have already been investigating sleep and its effects on the population for a long period. One of the current focuses is on sleep apnea, a sleep disorder characterized by frequent stops in breathing. Consequences of anti snoring could be serious, including hypertension, stroke and cardiovascular disease, and currently affects over 18 million Americans. Sleep apnea study, therefore, can benefit a significant portion of the populace.
The National Sleep Foundation, the American ANTI SNORING Association, and The National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke and the National Center on Sleep Disorders Research, certainly are a few organizations who conduct sleep apnea studies. These sleep apnea study researchers not merely examine the origin and the effects of the disorder, but other diseases and disorders which can be affected by anti snoring.
One such anti snoring study may be the National Heart, Lung, and Blood Institute (NHLBI) of NIH’s “Sleep Heart Health Study” (SHHS). NHLBI reported in April of 2000 that middle-aged and older adults with anti snoring showed a 45 percent greater threat of hypertension–a major risk factor for coronary disease. The sleep apnea study involved a lot more than 6,000 adults aged 40 and over, whose anti snoring was assessed via in the home polysomnography (PSG). PSG records body activity while asleep, such as eye movement, heartrate, respiratory effort, airflow and blood oxygen levels. The result: the chance of hypertension increased with the severe nature of the apnea in all participants, no matter age, sex, race, or weight. The chance was evident even at moderate levels of sleep apnea.
A different anti snoring study, conducted by Jana R. Cooke, MD, of the University of California at San Diego, examined patients with both Alzheimer disease and a sleep-related breathing disorder. This study focused on 48 adults, average age 77.8 years, treating them for the sleep disorder with CPAP, continuous positive airway pressure, the most common treatment for anti snoring. 鼻鼾 : the patients slept more during the night and slept deeper. Since waking episodes certainly are a problem for Alzheimer’s patients, improving their sleep, improved their standard of living.
A third sleep apnea study, performed at the St. George Hospital, University of New South Wales in Koragah, Australia, focused on the effectiveness of oral devices to keep the airway available to relieve anti snoring. The sleep apnea study consisted of four weeks of treatment with the MAS, and a device (an inactive oral appliance). Anti snoring tests were performed on each patient by the end of each treatment period. Results showed that in 59 men and 14 women of the average age of 48 years, the MAS Therapy improved a range of symptoms associated with anti snoring. Daytime sleepiness was reduced, as was sleep latency (enough time it takes to drift off once lights are out.)
These three sleep apnea studies are but a small portion of research projects for anti snoring. NIH’s currently lists over 50 sleep apnea studies on the website as “in progress” or “looking for subjects.